Literature DB >> 1958088

Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.

R E Chambers1, C W Hutton, P A Dieppe, J T Whicher.   

Abstract

The responses of C reactive protein, measured by radial immunodiffusion and radioimmunoassay, and serum amyloid A protein, measured by radial immunodiffusion, were compared in eight subjects with inflammation induced experimentally by intradermal injection of monosodium urate crystals. A significant increase in serum amyloid A was noted after a lag phase of eight hours, the increase in median concentration at 48 hours being about eightfold. A parallel but less marked increase was found in C reactive protein when measured by radioimmunoassay (fourfold increase in median concentration at 48 hours) after a small but significant decrease during the lag phase. The changes in C reactive protein remained within the reference range and were not detectable by radial immunodiffusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958088      PMCID: PMC1004528          DOI: 10.1136/ard.50.10.677

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia.

Authors:  I F Rowe; A M Worsley; P Donnelly; D Catovsky; J M Goldman; D Galton; M B Pepys
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

Review 2.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

3.  Measurement of serum amyloid A protein concentrations as test of renal allograft rejection.

Authors:  M B Pepys
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-17

4.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

5.  Early time course of the acute phase protein response in man.

Authors:  C M Colley; A Fleck; A W Goode; B R Muller; M A Myers
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

6.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

7.  Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease.

Authors:  J G Raynes; E H Cooper
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

8.  Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity.

Authors:  R E Chambers; D G MacFarlane; J T Whicher; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

9.  Quantitative radial immunodiffusion assay for serum amyloid A protein.

Authors:  R E Chambers; J T Whicher
Journal:  J Immunol Methods       Date:  1983-04-15       Impact factor: 2.303

10.  Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease.

Authors:  R E Chambers; P Stross; R E Barry; J T Whicher
Journal:  Eur J Clin Invest       Date:  1987-10       Impact factor: 4.686

View more
  2 in total

1.  Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs.

Authors:  Michelle B Christensen; Rebecca Langhorn; Amelia Goddard; Eva B Andreasen; Elena Moldal; Asta Tvarijonaviciute; Jolle Kirpensteijn; Sabrina Jakobsen; Frida Persson; Mads Kjelgaard-Hansen
Journal:  Can Vet J       Date:  2014-02       Impact factor: 1.008

2.  Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone.

Authors:  J W Smith; T L McDonald
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.